InVivo appoints Dr. Richard Toselli CEO: 5 things to know

InVivo Therapeutics named Richard Toselli, MD, permanent CEO and president. He had been serving as acting CEO since Dec. 2017.

Advertisement

Here are five things to know:

 

1. In addition to serving as CEO, Dr. Toselli will serve on the company’s board of directors.

 

2. Dr. Toselli will continue serving as CMO, a role he has been serving since joining InVivo in July 2017.

 

3. Throughout his career, Dr. Toselli held leadership positions at DePuy Synthes, Johnson & Johnson and Sanofi.

 

4. Dr. Toselli is a board-certified neurosurgeon specializing in spine surgery.

 

5. He previously served as the director of the spine center at Chapel Hill-based University of North Carolina.

 

More articles on devices and implants:
Ceterix Orthopaedics completes enrollment in NovoStitch meniscal repair study: 4 things to know
OrthoXel’s Apex Tibial Nailing System receives approval to hit U.S. and European markets: 4 insights
Stryker, Smith & Nephew, Zimmer Biomet & more: 10 device company notes

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.